威尔逊病患者的死亡率增加四倍:对151名患者的基于人口的队列研究
Fredrik Åberg1, Ying Shang2, Rickard Strandberg2
1Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
与一般人群相比,患有威尔逊病的患者面临的死亡风险几乎高出四倍. 这项研究强调了威尔逊病患者心血管,精神和神经疾病的风险增加.
科学领域:
- 医学研究 医学研究
- 流行病学 流行病学
- 遗传学 是一个遗传学.
背景情况:
- 威尔逊病是一种罕见的遗传疾病,影响铜代谢.
- 与一般人群相比,对威尔逊病患者的死亡率和临床结果的数据有限.
研究的目的:
- 在基于人口的威尔逊病患者队列中调查死亡率和临床结果.
- 将这些结果与来自一般人口的匹配个体进行比较.
主要方法:
- 全国范围的瑞典登记册被用来识别威尔逊病患者 (2002-2020年).
- 根据年龄,性别和市区,患者与多达10个一般人口对照进行了匹配.
- 使用经过验证的注册表,对结果进行了长达19年的跟踪.
主要成果:
- 151名威尔逊病患者与1441名对照人群进行了匹配.
- 威尔逊病患者的死亡风险增加了3.8倍 (HR 3.8).
- 在威尔逊病患者中观察到心血管,精神和神经系统疾病的风险增加.
结论:
- 威尔逊病与显著增加的死亡率有关.
- 患有威尔逊病的患者患有更高的心血管,精神和神经疾病.
- 这项研究强调了威尔逊病超出肝脏并发症的系统性影响.
更多相关视频
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
相关概念视频
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hemodialysis II: Procedure and Complications
